PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cancer researchers awarded $3.2 million grant to find better ways to treat advanced melanoma

2024-03-11
(Press-News.org) A team of investigators from the UCLA Health Jonsson Comprehensive Cancer and the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute was awarded a $3.2 million grant from the National Institutes of Health to identify new ways to prevent and overcome treatment resistance to targeted therapy in patients with all sub-types of cutaneous melanoma, an aggressive form of skin cancer. 

Virtually all cutaneous melanomas display genetic alterations that activate a cancer-driving pathway called MAPK. In about half of advanced cutaneous melanomas, specific mutations in a protein called BRAF provide targets for a currently approved MAPK-targeted therapy. While some patients with BRAF mutated melanomas respond to existing MAPK-targeted therapy, many develop resistance over time, leading to clinical relapses and more aggressive cancers. For the other half of patients with melanomas lacking the specific BRAF mutations, there is currently no FDA-approved options for treatment with MAPK-targeted drugs. In order to improve existing and develop new treatments, it is critical to understand how all melanomas evolve resistance in response to one or two drugs aimed at turning off the MAPK pathway.

The new grant, led by Dr. Roger Lo, professor of medicine and molecular and medical pharmacology at the David Geffen School of Medicine at UCLA, and Alan Tackett, professor of biochemistry and molecular biology at UAMS, supports their work in creating the Melanoma Resistance Evolution Atlas (MREA). This atlas, which uses fragments of tumors from patient biopsies and implanted to grow in specialized mice, will allow the team to test different combination therapies. A technical core facility creating these specialized mice is directed by Gatien Moriceau, assistant adjunct professor of medicine at the David Geffen School of Medicine at UCLA.

The team will then examine the unique characteristics and behaviors of each patient’s tumor, before and after it is treated with MAPK-targeted drugs as well as when it stops responding all together. They will use proteogenomic and single-cell analyses to identify new drug targets to design future experimental combination therapies. The MREA will comprise rich data matched to individual patients represented by the mouse models, serving as a unique resource for the broader cancer research field.

“It is really important for the field to use a comprehensive set of in vivo models that reflect the full-spectrum of patient-specific disease sub-types to generate rich multi-omic data on how melanomas respond to and then evolve resistance to evade this important type of therapy,” said Tackett. 

“We will use current and newer MAPK-targeting agents as foundations to add other types of drugs,” said Lo. “Better MAPK inhibitor-based combination treatments will benefit not only patients with melanoma but also a large fraction of patients with other types of common and aggressive tumors such as lung and colorectal cancers.”

END


ELSE PRESS RELEASES FROM THIS DATE:

The liver immune system eats up ‘bad cholesterol’

2024-03-11
A new study from Karolinska Institutet in Sweden reveals that immune cells in the liver react to high cholesterol levels and eat up excess cholesterol that can otherwise cause damage to arteries. The findings, published in Nature Cardiovascular Research, suggest that the response to the onset of atherosclerosis begins in the liver. Cholesterol is a type of fat that is essential for many functions in the body, such as making hormones and cell membranes. However, too much cholesterol in the blood can be harmful, as it can stick to the walls of the arteries ...

New study finds female entrepreneurs do better with guidance from female mentors

2024-03-11
INFORMS Journal Marketing Science Study Key Takeaways: Female entrepreneurs increase their chances of success and improved performance with female mentors. One of the key benefits to female entrepreneurs is a mentoring style characterized as “positive engagement.”   BALTIMORE, MD, March 11, 2024 – In business and in life, the power of mentorship has long been understood, but how important is it that your mentor look like you? This question was at the center of a new study, which specifically found that mentor gender has a powerful impact on ...

Using wrist-worn activity trackers to help patients reduce long COVID symptoms

2024-03-11
  LA JOLLA, CA—Scientists at the Scripps Research Digital Trials Center have partnered with the health technology company CareEvolution to launch a remote study that will investigate whether wrist-worn devices, such as activity trackers and smartwatches, can help people with long COVID manage and reduce the severity of their symptoms. “New treatments and interventions are urgently needed,” says the study principal investigator Julia Moore Vogel, PhD. “We’re excited to launch the Long COVID Wearable Study and ...

AI-generated food images look tastier than real ones

2024-03-11
With the Global Nutrition and Hydration Week 2024 starting today, researchers have announced an intriguing discovery – consumers generally prefer AI-generated images of food over real food images, especially when they are unaware of their true nature. The new findings have been published in Food Quality and Preference. According to the researchers, the results suggest that AI-generated food visuals excel at enhancing the appeal of depicted foods by leveraging key features such as symmetry, shape, glossiness, and overall lighting and colour. All of these are known to contribute significantly ...

Implantable brain-computer interface collaborative community (iBCI-CC) to drive innovation in neurotechnology

2024-03-11
BOSTON – (March 11, 2024) Mass General Brigham is establishing the Implantable Brain-Computer Interface Collaborative Community (iBCI-CC). This is the first Collaborative Community in the clinical neurosciences that has participation from the U.S. Food and Drug Administration (FDA). BCIs are devices that interface with the nervous system and use software to interpret neural activity. Commonly, they are designed for improved access to communication or other technologies for people with physical disability. Implantable BCIs are investigational devices ...

Political rage on social media is making us cynical

2024-03-11
Political anger and cynicism are rising in the United States and in many democracies worldwide, and both are associated with exposure to political attacks on social media, a new University of Michigan study shows.   Americans use social media to find information and news about politics, but much of the content they see in their feeds is hostile, uncivil and attacking, said lead author Ariel Hasell, assistant professor of communication and media and an affiliate of the Center for Political Studies at the U-M Institute for Social Research.    Hasell ...

Emergency room culture may deter medical students from selecting specialty

2024-03-11
FINDINGS   In a new UCLA Health study, 25 medical students pursuing emergency medicine were interviewed about their experiences working in an emergency room during clinical rotations. Four themes were identified in their answers: watching difficult interactions between patient and care team and among the care team was distressing; women participants found that culture to be exclusionary; traits – like assertiveness and self-advocacy – were favored; and access to mentors, representation, and exposure to environment influenced interest towards the specialty.  Most of the medical students interviewed -- 21 ...

CPRIT grant supports UH College of Pharmacy fight against rare genetic disorder

CPRIT grant supports UH College of Pharmacy fight against rare genetic disorder
2024-03-11
The University of Houston College of Pharmacy is included in a $68.5 million funding package from the Cancer Prevention and Research Institute of Texas (CPRIT).   Ming Hu, Diana S-L. Chow Endowed Professor of Drug Discovery and Development, and Gregory Cuny, Joseph P. & Shirley Shipman Buckley Endowed Professor of Drug Discovery, received $1.4 million to fight familial adenomatous polyposis (FAP), a devastating and rare genetic disorder of the gastrointestinal tract that can cause hundreds or thousands of polyps inside the colon ...

Trauma screening may improve mental health service recommendations for children

2024-03-11
UNIVERSITY PARK, Pa. — Each year between 200,000 and 270,000 children and youth enter foster care placements with child welfare services, and many more children receive child welfare services while remaining in their parent's care, according to the U.S. Department of Health and Human Services. Although many of these children have a documented history of abuse or neglect, children may respond differently to incidents of maltreatment or other potentially traumatic events. Incorporating a trauma screening — which assesses how trauma and maltreatment affected each child — into the child welfare evaluation process provides information that could be used to ...

Wrist device that monitors activity could help provide early warning of Alzheimer’s

2024-03-11
Monitoring daily activity patterns using a wrist-worn device may detect early warning signs of Alzheimer’s disease, according to a new study led by researchers at the Johns Hopkins Bloomberg School of Public Health. The researchers analyzed movement data from wristwatch-like devices called actigraphs worn by 82 cognitively healthy older adults who were participants in a long-running study of aging. Some of the participants had detectable brain amyloid buildup as measured by PET scan. Buildup of the protein amyloid beta in the brain is a key feature of Alzheimer’s disease. Using a sensitive statistical technique, the ...

LAST 30 PRESS RELEASES:

Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage

Negativity about vaccines surged on Twitter after COVID-19 jabs become available

Global measles cases almost double in a year

Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen

Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds

Experts developing immune-enhancing therapies to target tuberculosis

Making transfusion-transmitted malaria in Europe a thing of the past

Experts developing way to harness Nobel Prize winning CRISPR technology to deal with antimicrobial resistance (AMR)

CRISPR is promising to tackle antimicrobial resistance, but remember bacteria can fight back

Ancient Maya blessed their ballcourts

Curran named Fellow of SAE, ASME

Computer scientists unveil novel attacks on cybersecurity

Florida International University graduate student selected for inaugural IDEA2 public policy fellowship

Gene linked to epilepsy, autism decoded in new study

OHSU study finds big jump in addiction treatment at community health clinics

Location, location, location

Getting dynamic information from static snapshots

Food insecurity is significant among inhabitants of the region affected by the Belo Monte dam in Brazil

The Society of Thoracic Surgeons launches new valve surgery risk calculators

Component of keto diet plus immunotherapy may reduce prostate cancer

New circuit boards can be repeatedly recycled

Blood test finds knee osteoarthritis up to eight years before it appears on x-rays

April research news from the Ecological Society of America

Antimicrobial resistance crisis: “Antibiotics are not magic bullets”

Florida dolphin found with highly pathogenic avian flu: Report

Barcodes expand range of high-resolution sensor

DOE Under Secretary for Science and Innovation visits Jefferson Lab

Research expo highlights student and faculty creativity

Imaging technique shows new details of peptide structures

MD Anderson and RUSH unveil RUSH MD Anderson Cancer Center

[Press-News.org] Cancer researchers awarded $3.2 million grant to find better ways to treat advanced melanoma